Bank of Nova Scotia’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.4M | Sell |
136,000
-6,000
| -4% | -$590K | 0.03% | 329 |
|
|
2025
Q1 | $13.2M | Buy |
142,000
+31,000
| +28% | +$2.87M | 0.03% | 320 |
|
|
2024
Q4 | $10.1M | Buy |
111,000
+71,000
| +178% | +$6.45M | 0.02% | 411 |
|
|
2024
Q3 | $3.86M | Sell |
40,000
-144,774
| -78% | -$14M | 0.01% | 515 |
|
|
2024
Q2 | $17M | Hold |
184,774
| – | – | 0.03% | 283 |
|
|
2024
Q1 | $17M | Sell |
184,774
-88,722
| -32% | -$8.18M | 0.03% | 295 |
|
|
2023
Q4 | $26M | Sell |
273,496
-12,061
| -4% | -$1.15M | 0.05% | 261 |
|
|
2023
Q3 | $26.7M | Buy |
+285,557
| New | +$26.7M | 0.07% | 196 |
|
|
2022
Q1 | – | Sell |
-45,307
| Closed | -$7.34M | – | 1167 |
|
|
2021
Q4 | $7.34M | Buy |
+45,307
| New | +$7.34M | 0.01% | 581 |
|
|
2021
Q3 | – | Sell |
-2,020
| Closed | -$495K | – | 1058 |
|
|
2021
Q2 | $495K | Buy |
2,020
+191
| +10% | +$46.8K | ﹤0.01% | 948 |
|
|
2021
Q1 | $484K | Sell |
1,829
-6,390
| -78% | -$1.69M | ﹤0.01% | 923 |
|
|
2020
Q4 | $2.41M | Buy |
8,219
+5,843
| +246% | +$1.71M | 0.01% | 636 |
|
|
2020
Q3 | $562K | Buy |
+2,376
| New | +$562K | ﹤0.01% | 814 |
|
|
2020
Q2 | – | Sell |
-4,250
| Closed | -$780K | – | 910 |
|
|
2020
Q1 | $780K | Sell |
4,250
-34,550
| -89% | -$6.34M | ﹤0.01% | 716 |
|
|
2019
Q4 | $6.48M | Sell |
38,800
-19,997
| -34% | -$3.34M | 0.02% | 474 |
|
|
2019
Q3 | $7.7M | Buy |
+58,797
| New | +$7.7M | 0.02% | 422 |
|